| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.006 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.009 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |